Company is expanding clinical trials of its psilocybin-based medicine. The post Compass Pathways Losses Tick Up on Increased R&D appeared first on...
Clairvoyant Therapeutics, a clinical stage biotech company focused on the development of psychedelic drug therapies for the treatment of addiction, is...
The article PharmaTher Enters into Agreement to Commercialize Ketamine for Rett Syndrome was originally published on Microdose. “We are pleased to have...
Silo Wellness Inc. (CSE: SILO | OTCQB: SILFF | FSE: 3K7A), Oregon’s only publicly traded psychedelics company, announces that the Jackson County Planning...
COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
The psychedelic compound in magic mushrooms – psilocybin – can improve the symptoms of severe depression, according to The post Largest-ever trial...
Revitalist Lifestyle and Wellness LTD. (CSE: CALM | OTCQB: RVLWF | FSE: 4DO), releases proprietary supplement lines to extend the results of psychedelic...
Despite a challenging economy, psychedelics companies have accelerated development. The post Recession Predictions Not Slowing Psychedelics Industry appeared...
Revitalist Lifestyle and Wellness LTD. (CSE: CALM | OTCQB: RVLWF | FSE: 4DO), partners with patient financing company allowing client lending up to $100,000...
Cybin Inc. (NEO:CYBN | NYSE American:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, today announced an upcoming...